SCHEMBL277793

SCHEMBL277793

CC(CCC=O)CC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10596471 0.86 HIF1A (0.38)
SCHEMBL1067841 0.79
SCHEMBL10063343 0.79 ALDH1A1 (0.31) ALDH1A1
SCHEMBL17381336 0.79 ALDH1A1 (0.42) ALDH1A1
SCHEMBL14215413 0.77
SCHEMBL277231 0.76
SCHEMBL9302609 0.76
SCHEMBL11763330 0.76 ALOX15 (0.39) ALDH1A1
SCHEMBL278048 0.76 ADH1B (0.39)
SCHEMBL272791 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240199779-A1 PRODUCT OF ACETALIZATION OF ETHYLENE/VINYL ALCOHOL COPOLYMER AND COMPOSITION CONTAINING SAID ACETALIZATION PRODUCT KURARAY CO., LTD. (JP) 2024-06-20 US disclosed
WO-2024085035-A1 ACETALIZATION PRODUCT OF ETHYLENEVINYL ALCOHOL COPOLYMER, COMPOSITION CONTAINING SAID ACETALIZATION PRODUCT, AND BARRIER MATERIAL 株式会社クラレ 2024-04-25 WO disclosed
US-20240101760-A1 METHOD FOR PRODUCING PRODUCT OF ACETALIZATION OF ETHYLENE/VINYL ALCOHOL COPOLYMER KURARAY CO., LTD. (JP) 2024-03-28 US disclosed
EP-4324798-A1 METHOD FOR PRODUCING PRODUCT OF ACETALIZATION OF ETHYLENE/VINYL ALCOHOL COPOLYMER Kuraray Co., Ltd. (JP) 2024-02-21 EP disclosed
EP-4324859-A1 PRODUCT OF ACETALIZATION OF ETHYLENE/VINYL ALCOHOL COPOLYMER AND COMPOSITION CONTAINING SAID ACETALIZATION PRODUCT Kuraray Co., Ltd. (JP) 2024-02-21 EP disclosed
US-20230382087-A1 GLASS LAMINATES WITH REDUCED CREEP AT ELEVATED TEMPERATURE KURARAY EUROPE GMBH (DE) 2023-11-30 US disclosed
EP-4204377-A1 GLASS LAMINATES WITH REDUCED CREEP AT ELEVATED TEMPERATURE Kuraray Europe GmbH (DE) 2023-07-05 EP disclosed
US-20230069427-A1 RESIN COMPOSITION, RESIN SHEET, AND LAMINATED GLASS KURARAY CO., LTD. (JP) 2023-03-02 US disclosed
EP-4092003-A1 RESIN COMPOSITION, RESIN SHEET, AND LAMINATED GLASS Kuraray Co., Ltd. (JP) 2022-11-23 EP disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-1947101-A1 HYDRAZIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR Nissan Chemical Industries, Ltd. (JP) 2008-07-23 EP disclosed
US-7351841-B2 Heterocyclic compounds and thrombopoietin receptor activators NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2008-04-01 US disclosed
US-20080027068-A1 HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES LIMITED (JP) 2008-01-31 US disclosed
EP-1845090-A1 AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR Nissan Chemical Industries, Ltd. (JP) 2007-10-17 EP disclosed
EP-1819692-A1 3-ETHYLIDENEHYDRAZINO SUBSTITUTED HETEROCYCLIC COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS Nissan Chemical Industries, Ltd. (JP) 2007-08-22 EP disclosed
CN-1798739-A 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators NISSAN CHEMICAL IND LTD (JP) 2006-07-05 CN disclosed
WO-2006062240-A1 3-ETHYLIDENEHYDRAZINO SUBSTITUTED HETEROCYCLIC COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2006-06-15 WO disclosed
US-20060094694-A1 Heterocyclic compounds and thrombopoietin receptor activators NISSAN CHEMICAL INDUSTRIES LIMITED (JP) 2006-05-04 US disclosed
US-6106999-A SENSITIVITY TO GENERAL-PURPOSE VISIBLE LIGHT LASER, SO THAT HIGH-SPEED SCANNING EXPOSURE IS POSSIBLE BY LASER, AND EXTREMELY FINE HIGH RESOLUTION CAN BE OBTAINED; CAN BE USED FOR COATING OR PRINTING UNDER SAFELIGHT IRRADIATING CONDITIONS MITSUI CHEMICALS (JP) 2000-08-22 US disclosed
US-5747627-A MIXTURE OF OXAZOLIDINE COMPOUND AND ORGANIC SILICIC ACID OR P-TOLUENESULFONYL ISOCYANATE COMPOUND; STORAGE STABILITY THE YOKOHAMA RUBBER CO., LTD. (JP) 1998-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094694-A1 Heterocyclic compounds and thrombopoietin receptor activators NR2C2, ROR1, NR0B2 ALDH1A1 3160/4885
US-20080027068-A1 HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NR2C2, ROR1, NR0B2 ALDH1A1 3206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.